XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income $ 236,400,000 $ 213,900,000 $ 629,900,000
Adjustments to reconcile net income to net cash provided by operating activities and other adjustments:      
Depreciation and amortization 625,100,000 593,100,000 508,700,000
(Gain) loss on sale or disposal of fixed assets (3,200,000) 1,900,000 2,400,000
Gain on divestiture of business 0 0 (5,000,000.0)
Loss on debt refinancing and prepayment 0 6,200,000 4,600,000
Amortization of debt discount and issuance costs 12,100,000 13,000,000.0 13,200,000
Payments for term debt modification 0 0 (1,100,000)
Share-based compensation 67,700,000 79,400,000 78,300,000
Non-cash interest on convertible notes 38,200,000 37,800,000 36,100,000
Non-cash asset impairment charges 17,500,000 3,400,000 2,400,000
Goodwill and intangible asset impairment charges 1,300,000 1,600,000 6,800,000
Change in deferred tax balances (122,600,000) 11,200,000 69,200,000
Other 10,500,000 (100,000) (1,600,000)
Changes in assets and liabilities (exclusive of the impact of acquisitions and divestitures):      
Receivables 31,400,000 4,700,000 (2,700,000)
Inventories (26,300,000) 34,600,000 (129,500,000)
Other assets (60,000,000.0) (34,600,000) (37,400,000)
Accounts payable 34,200,000 (79,900,000) 44,800,000
Accrued expenses and other current liabilities (18,500,000) (201,700,000) 56,500,000
Other long-term liabilities 40,500,000 10,200,000 (1,400,000)
Net cash provided by operating activities 884,300,000 694,700,000 1,274,200,000
Cash flows from investing activities:      
Purchase of property, plant and equipment (383,600,000) (534,600,000) (514,800,000)
Proceeds from sale of property, plant and equipment 6,300,000 1,900,000 36,500,000
Deposits utilized for purchases of property, plant and equipment 2,200,000 4,600,000 4,100,000
Purchase of business, net of cash acquired (4,500,000) (888,000,000.0) (70,900,000)
Settlement of purchase price and purchase of equity interest and assets, net of cash acquired 26,000,000.0 0 (24,600,000)
Purchase of license and deposit made for manufacturing facility (100,000,000.0) (100,000,000.0) 0
Proceeds from divestiture of business and release of escrow 0 5,200,000 8,400,000
Proceeds from repayment of note receivable 0 0 10,200,000
Other 0 0 2,200,000
Net cash used in investing activities (453,600,000) (1,510,900,000) (548,900,000)
Cash flows from financing activities:      
Proceeds for the issuance of common stock under the ESPP 23,600,000 26,200,000 25,000,000.0
Proceeds from exercise of stock options 0 1,700,000 5,700,000
Payments of tax withholding for RSUs (20,000,000.0) (33,500,000) (31,600,000)
Repurchase of common stock (65,400,000) (139,000,000.0) (315,300,000)
Issuance and borrowings under debt agreements 1,858,000,000.0 1,404,800,000 15,300,000
Payment of debt issuance and other financing costs (2,400,000) (24,000,000.0) 0
Repayment of borrowings under debt agreements (2,023,900,000) (594,400,000) (298,400,000)
Release of escrow related to prior acquisition 0 (10,400,000) 0
Payment of finance lease obligations 0 (800,000) (3,600,000)
Payments related to prior acquisition (8,900,000) (5,200,000) 0
Dividend to non-controlling shareholder (5,000,000.0) (2,300,000) (2,200,000)
Net cash provided by (used in) financing activities (244,000,000.0) 623,100,000 (605,100,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 600,000 200,000 300,000
Net increase (decrease) in cash, cash equivalents and restricted cash 187,300,000 (192,900,000) 120,500,000
Cash, cash equivalents and restricted cash, beginning of period (Note 18) 894,200,000 1,087,100,000 966,600,000
Cash, cash equivalents and restricted cash, end of period (Note 18) $ 1,081,500,000 $ 894,200,000 $ 1,087,100,000